Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18603,146,1.22 [0.91-1.63],0.1786908519173985
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19562,203,1.23 [0.96-1.58],0.1040113704412734
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19336,1408,1.22 [1.11-1.34],5.823107717276584e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19577,442,1.14 [0.95-1.36],0.1581413533255346
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18930,3442,1.16 [1.09-1.24],1.8773219844096708e-06
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18912,3498,1.21 [1.14-1.28],1.943402557734714e-09
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19331,1156,1.17 [1.04-1.30],0.0062246034288339
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19489,107,1.32 [0.95-1.84],0.1019495437859639
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17269,1023,1.30 [1.16-1.45],3.209788951168228e-06
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16637,1233,1.35 [1.22-1.50],3.3541724927157038e-09
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16300,267,1.43 [1.16-1.76],0.0009848341260335
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12748,2210,1.21 [1.12-1.30],2.066412058154942e-06
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16246,392,1.48 [1.25-1.75],6.085028071362108e-06
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19544,1369,1.16 [1.05-1.29],0.0031864521909754
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,19647,512,1.12 [0.95-1.33],0.167893411588313
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18922,994,1.27 [1.13-1.42],3.314493871558913e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19588,1131,1.24 [1.12-1.37],5.334712286639903e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18378,203,1.24 [0.97-1.60],0.0840591855636288
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19697,51,1.19 [0.72-1.98],0.5024005319554975
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19444,987,1.25 [1.12-1.39],8.537843247799188e-05
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19447,65,1.20 [0.76-1.87],0.4344378910200241
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19642,112,1.23 [0.88-1.74],0.2281791063051888
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19627,97,1.25 [0.87-1.80],0.2314003566234784
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18315,387,1.18 [0.98-1.42],0.0779317456987406
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18179,251,1.21 [0.97-1.52],0.0921320170375743
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18277,102,1.39 [1.00-1.95],0.0516194991433034
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19682,47,1.09 [0.64-1.86],0.7519205578678907
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19636,146,1.49 [1.16-1.91],0.0018876286479457
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral warts,19538,48,1.38 [0.87-2.19],0.1732558671313139
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19561,71,1.74 [1.29-2.34],0.0002928605976363
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,19458,220,0.94 [0.73-1.23],0.666703352626864
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19627,38,1.22 [0.68-2.18],0.5080876912424401
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19609,38,0.59 [0.30-1.14],0.1147682730852957
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9309,67,1.06 [0.68-1.63],0.8097919682441712
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19308,1410,1.02 [0.92-1.13],0.7612805688806976
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of meninges,19684,57,0.93 [0.54-1.59],0.7784982116284608
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19618,70,1.58 [1.15-2.17],0.0047866909153746
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19675,101,0.98 [0.66-1.46],0.9380238048978248
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of ovary,10338,65,0.94 [0.56-1.59],0.8248211585446369
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19662,380,1.13 [0.94-1.36],0.2070070806784133
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Caecum,19674,325,1.05 [0.85-1.29],0.6726787360503581
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19571,76,0.78 [0.49-1.23],0.283508608286648
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19661,218,1.12 [0.88-1.44],0.3614666192379264
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,19618,340,0.91 [0.74-1.13],0.4015992634760542
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19568,592,1.08 [0.93-1.26],0.3279725959459576
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19653,449,1.06 [0.88-1.26],0.551581140371457
RLN2,Prorelaxin H2,Chapter II Neoplasms,Carcinoma in situ of breast,7787,44,1.48 [0.93-2.38],0.1005052160545108
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7820,54,1.08 [0.61-1.92],0.7974448911441131
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14120,62,0.62 [0.37-1.05],0.0777432931090855
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14141,83,0.68 [0.43-1.08],0.1029005223900372
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19647,109,1.06 [0.73-1.53],0.7772623755288129
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",19648,106,1.02 [0.70-1.49],0.9188434066342328
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,10107,145,0.99 [0.69-1.40],0.942098834989647
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lung cancer and mesothelioma,12551,421,1.07 [0.89-1.29],0.4850863881001264
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lymphoid leukaemia,14120,62,0.71 [0.42-1.20],0.2069427617213471
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14244,186,1.00 [0.75-1.32],0.9776624025446096
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14310,252,1.25 [1.01-1.54],0.037205673419643
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7901,97,0.96 [0.62-1.48],0.8453896256353017
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14152,94,1.04 [0.70-1.55],0.8300894714473577
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14182,124,1.68 [1.36-2.07],1.4712818376700953e-06
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14168,110,1.02 [0.71-1.46],0.9241485494794552
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7882,78,0.77 [0.47-1.25],0.2876200640086842
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14166,108,0.94 [0.64-1.37],0.7376707951236958
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7057,803,1.14 [1.01-1.28],0.0355779557165928
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14169,111,0.81 [0.55-1.19],0.2862710210697622
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14137,79,0.92 [0.60-1.43],0.7214883437392609
RLN2,Prorelaxin H2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14176,118,1.39 [1.04-1.84],0.0246155054801842
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,19571,159,0.91 [0.66-1.25],0.544179094776833
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of trunk,19674,66,0.86 [0.53-1.40],0.5363179464198415
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanoma in situ,14104,98,0.89 [0.59-1.34],0.5849848750101276
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14162,104,0.78 [0.52-1.17],0.2287669131801463
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14227,169,1.02 [0.76-1.38],0.8869501583210747
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14352,294,0.90 [0.71-1.14],0.3876802142773859
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14167,109,1.18 [0.84-1.66],0.3504437115251726
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,19554,143,1.11 [0.81-1.53],0.5125001053509228
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15297,1239,0.97 [0.87-1.09],0.6000927575901216
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15363,1305,0.98 [0.88-1.09],0.6705454888054031
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19442,319,1.10 [0.89-1.36],0.3766449347395944
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17800,105,1.49 [1.12-1.99],0.0068450024265746
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19182,59,1.33 [0.86-2.07],0.2029301907339645
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19085,2874,1.16 [1.08-1.24],2.2828182706821287e-05
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18293,59,1.30 [0.84-2.00],0.2400747050254135
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19312,60,1.90 [1.49-2.43],2.911727308985523e-07
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19296,1601,1.16 [1.06-1.27],0.0017780632609469
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19294,1599,1.16 [1.05-1.27],0.0020828715020311
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17788,93,1.38 [0.98-1.94],0.0670401294171618
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19399,1165,1.17 [1.05-1.30],0.0045299825682239
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19349,97,1.51 [1.11-2.05],0.0080348991844587
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19182,59,1.54 [1.06-2.24],0.0242278495654482
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19190,67,0.93 [0.57-1.51],0.7658638367569074
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19546,294,1.57 [1.34-1.84],3.2665583668541644e-08
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19591,32,1.36 [0.77-2.40],0.2892714666738785
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19490,238,1.53 [1.27-1.84],5.917543817759807e-06
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18344,110,0.96 [0.66-1.40],0.8294056478167948
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13375,329,1.30 [1.08-1.57],0.0056541092227177
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18439,85,0.72 [0.45-1.17],0.186519237019778
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18444,90,0.59 [0.38-0.92],0.019350352750209
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13108,62,1.52 [1.03-2.23],0.0348234960009155
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18355,42,1.11 [0.62-2.00],0.725125286514582
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17729,263,0.99 [0.77-1.26],0.9053245877110816
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19058,745,0.99 [0.86-1.14],0.8760239574543383
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18719,406,0.93 [0.76-1.14],0.4725291298264921
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18458,145,0.86 [0.62-1.20],0.373557778074872
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19474,1161,1.15 [1.03-1.29],0.0125015096747349
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16674,1131,1.16 [1.04-1.30],0.0086814644386665
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13110,64,1.55 [1.08-2.23],0.0176318958385964
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17795,84,0.59 [0.38-0.94],0.0256137613753628
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13345,299,1.22 [0.99-1.51],0.0670007945818787
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13092,46,1.31 [0.78-2.18],0.3054757451165037
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16853,3807,1.05 [0.99-1.12],0.1350106363392273
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13270,224,0.96 [0.74-1.26],0.7697553832746571
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13626,580,1.05 [0.89-1.23],0.5532496715378673
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19651,302,1.13 [0.91-1.40],0.2610228541308582
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19471,122,1.63 [1.27-2.08],9.66975282461772e-05
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13167,121,0.76 [0.53-1.11],0.152711170336106
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13114,68,1.08 [0.69-1.71],0.7311754108806009
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19161,1450,1.21 [1.10-1.34],0.0001442700282455
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13358,312,1.48 [1.24-1.76],1.4329150274101928e-05
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13367,321,1.65 [1.42-1.92],9.885540789424656e-11
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13755,709,1.18 [1.02-1.35],0.0212536901158312
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13173,127,1.04 [0.74-1.46],0.8192322496684034
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19466,117,1.66 [1.30-2.11],4.232972391939609e-05
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13790,744,1.00 [0.87-1.15],0.9891345653067408
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13578,532,1.08 [0.91-1.28],0.3709866301613724
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17524,58,1.08 [0.65-1.80],0.7561145886895517
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18390,5344,1.08 [1.03-1.14],0.0026796129192278
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17758,47,0.93 [0.51-1.69],0.8179323096981896
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17757,46,0.95 [0.52-1.74],0.8690353244662326
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19553,1552,1.07 [0.97-1.18],0.15177488840192
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19551,1550,1.07 [0.98-1.18],0.1422498779120412
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17766,55,1.16 [0.68-1.96],0.5882648015012122
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19396,955,1.16 [1.03-1.32],0.0161348571202939
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14871,1825,1.18 [1.08-1.28],0.0001816439893773
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19686,240,1.30 [1.05-1.62],0.0170095657489684
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18404,91,1.00 [0.67-1.50],0.985653865701696
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18538,97,0.76 [0.50-1.15],0.1940095614227791
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18585,144,1.20 [0.87-1.64],0.2691145998453742
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13210,164,1.30 [0.98-1.74],0.0716898973751899
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17355,156,1.24 [0.93-1.64],0.1394344495693267
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2101,80,1.20 [0.81-1.77],0.3714994575657516
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2234,246,1.04 [0.82-1.32],0.7361695960457071
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17267,68,1.50 [1.06-2.12],0.0219598345981748
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2067,47,1.81 [1.25-2.63],0.0018609380878167
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19006,1807,1.06 [0.97-1.16],0.1920199010883251
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18815,502,1.12 [0.95-1.33],0.1804232481197924
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17833,367,1.27 [1.05-1.54],0.0132874260825446
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13928,882,1.15 [1.02-1.31],0.0277703815491945
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19581,260,1.11 [0.88-1.41],0.3637628368234511
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18467,229,1.15 [0.91-1.45],0.2565604143895264
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,17081,1279,0.99 [0.89-1.10],0.8907118216940317
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18552,314,1.01 [0.82-1.25],0.9194490206307888
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18305,67,0.98 [0.61-1.59],0.9449521888332232
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18468,230,1.01 [0.78-1.31],0.917886463963788
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10074,2367,1.05 [0.97-1.13],0.2058891752271419
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,AV-block,15073,553,1.18 [1.02-1.38],0.0256685461224169
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19627,465,0.99 [0.83-1.18],0.9140469199210164
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7928,221,1.38 [1.15-1.66],0.000439994021
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14689,169,1.11 [0.83-1.49],0.4637896723019217
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14607,87,1.13 [0.76-1.69],0.5355928621021583
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19691,61,0.86 [0.52-1.42],0.5618345604239159
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,15804,1284,1.08 [0.98-1.20],0.1364141719518825
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18083,2303,1.07 [0.99-1.15],0.0976280756577049
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15972,7578,1.04 [0.99-1.09],0.091476289610969
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18373,286,1.12 [0.90-1.40],0.2979046160112104
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Endocarditis,14596,76,1.39 [0.98-1.99],0.0684528588277461
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19456,1369,1.18 [1.07-1.30],0.0009884015697762
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,17012,6689,1.04 [1.00-1.09],0.0720355042695125
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17016,6693,1.05 [1.00-1.09],0.0631583923833859
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19554,85,1.09 [0.74-1.61],0.6533160486149855
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10562,239,1.36 [1.11-1.66],0.0025167017280477
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10450,127,1.81 [1.55-2.11],4.798874198211845e-14
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,19546,1313,1.13 [1.02-1.25],0.0191105059220611
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18628,123,0.82 [0.57-1.18],0.2878414732817185
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18229,2427,1.05 [0.98-1.14],0.1659115481430514
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19274,662,1.11 [0.96-1.28],0.160563029686552
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14944,424,1.04 [0.86-1.25],0.6825937284194943
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19144,893,1.12 [0.99-1.26],0.0746475813303079
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16568,766,1.17 [1.03-1.33],0.0157171976012461
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19583,164,1.21 [0.92-1.59],0.1667048319883078
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19659,338,1.04 [0.84-1.27],0.73838711127722
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18145,58,1.39 [0.94-2.05],0.094699801219131
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other aneurysm,18326,88,1.25 [0.86-1.80],0.2436243442147269
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15012,492,1.22 [1.04-1.43],0.0132800006843189
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18347,109,1.11 [0.77-1.59],0.5743038205551769
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18506,268,1.20 [0.96-1.50],0.1088823920634352
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14711,191,0.82 [0.61-1.11],0.2009690267936905
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18176,89,0.98 [0.65-1.47],0.926656413813991
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18126,39,0.93 [0.50-1.72],0.8054563338861263
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18018,71,0.97 [0.61-1.54],0.9041780083510748
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18227,140,1.02 [0.74-1.40],0.9106722495123638
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15702,1182,1.13 [1.02-1.25],0.0241425164774172
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18283,50,1.27 [0.79-2.05],0.3279800122081862
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18841,603,1.11 [0.95-1.30],0.1720173516868328
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19050,461,1.30 [1.11-1.53],0.0011378020585038
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18741,794,1.11 [0.98-1.27],0.1098847008181779
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8049,342,1.26 [1.07-1.49],0.0053237578361336
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18694,489,1.20 [1.02-1.41],0.0261743412934303
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18445,358,1.08 [0.88-1.32],0.4523460125634247
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19083,494,1.24 [1.06-1.46],0.0085032089760168
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19613,802,1.21 [1.06-1.37],0.0036200291676762
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14950,430,1.05 [0.87-1.25],0.6152489240974948
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19045,456,1.30 [1.10-1.52],0.0016288385187513
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18156,209,1.28 [1.01-1.62],0.0390682902164207
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19258,753,1.06 [0.92-1.21],0.4281752102448211
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19247,785,1.07 [0.93-1.22],0.3458376192444877
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18603,50,1.30 [0.79-2.13],0.3003268451901666
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18318,80,0.66 [0.42-1.05],0.0781231048087612
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18877,265,1.10 [0.88-1.39],0.4001358311587837
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18529,278,1.07 [0.85-1.33],0.565853152188893
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,18519,432,1.11 [0.93-1.33],0.234753820790227
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18253,97,0.98 [0.65-1.47],0.9077145156167488
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19456,782,1.15 [1.00-1.31],0.0426097151894732
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19628,276,0.75 [0.59-0.96],0.0212581851093509
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16943,1165,1.15 [1.03-1.29],0.0128451177025248
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,19260,3482,1.08 [1.01-1.15],0.0275200893433337
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19603,325,0.75 [0.60-0.95],0.0149366570493833
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16957,1179,1.15 [1.03-1.29],0.0109594982141874
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15843,65,1.28 [0.81-2.01],0.2898691079384733
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,19265,978,1.04 [0.92-1.18],0.5142602176152258
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16983,1205,1.01 [0.90-1.13],0.9147566391229665
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Vascular dementia,18992,191,0.80 [0.60-1.08],0.1415246052569961
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Alzheimer disease,19694,500,1.00 [0.84-1.20],0.9698387351734272
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12293,95,0.61 [0.40-0.92],0.0197128717293898
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Bell's palsy,18161,71,1.31 [0.87-1.97],0.2009339363082203
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18512,422,0.89 [0.73-1.08],0.233548234930443
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral cysts,19327,200,1.13 [0.87-1.47],0.3427514194866201
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19634,326,1.06 [0.86-1.30],0.6021833273938364
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19001,72,0.93 [0.59-1.47],0.7628126133787623
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19679,61,1.04 [0.64-1.67],0.8870038819025338
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19195,68,0.70 [0.43-1.16],0.1666929446217096
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,18454,244,1.06 [0.83-1.35],0.6663765267705504
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19312,1102,1.17 [1.05-1.30],0.0056713133363445
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19645,530,0.95 [0.80-1.12],0.5163232987319102
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19143,2806,1.03 [0.95-1.11],0.4802812116509922
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19387,42,1.55 [0.98-2.47],0.0610076093169527
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,19573,265,1.13 [0.90-1.42],0.2844127816740436
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hydrocephalus,19187,60,0.81 [0.48-1.37],0.4355756049661693
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19683,56,1.06 [0.64-1.78],0.8108503452822995
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18150,60,1.27 [0.80-2.02],0.3043321323301152
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18151,61,1.11 [0.69-1.78],0.6682636094710444
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Memory loss,18783,133,1.07 [0.76-1.49],0.7110468805016005
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,18443,233,1.49 [1.22-1.83],0.0001228589800797
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19652,212,1.47 [1.18-1.84],0.000534569789185
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Motor neuron disease,12386,166,1.06 [0.78-1.43],0.7177561847695865
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19590,52,1.02 [0.59-1.75],0.9539810650147904
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19109,1019,1.00 [0.88-1.13],0.9743317680230592
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,18464,3496,1.02 [0.96-1.09],0.5201410209196594
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19171,242,0.97 [0.76-1.25],0.8251433172848881
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18426,336,1.07 [0.87-1.32],0.5137488947997593
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19630,290,1.27 [1.04-1.55],0.0200818141657727
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14961,804,1.01 [0.88-1.16],0.8976807592381967
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19194,67,1.20 [0.78-1.86],0.4062867769349247
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19259,132,1.05 [0.76-1.46],0.752566022541335
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19291,176,1.25 [0.96-1.64],0.0992206922381291
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18168,78,1.29 [0.87-1.91],0.2123828646769754
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other headache syndromes,18256,46,1.27 [0.76-2.13],0.3681016933284367
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,19601,474,1.07 [0.90-1.28],0.4333456877865065
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,18623,413,1.17 [0.99-1.38],0.0695844802464193
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Parkinson's disease,19663,333,0.87 [0.70-1.08],0.1945914852180729
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19166,39,1.46 [0.86-2.47],0.1586518572343669
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19693,76,0.79 [0.49-1.27],0.3319011502689594
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,19513,358,1.14 [0.95-1.37],0.1681814473614441
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19391,51,1.37 [0.87-2.14],0.1700891743316975
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19682,185,1.01 [0.76-1.34],0.9517807417499354
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18148,58,0.81 [0.47-1.39],0.4395182131561775
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19694,505,1.00 [0.84-1.19],0.9845379111025188
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18937,185,0.80 [0.59-1.08],0.1438768246005552
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19169,124,1.20 [0.86-1.68],0.2824784193008413
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19322,469,1.10 [0.92-1.31],0.3155244115160731
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19499,217,0.94 [0.73-1.22],0.6534802357363865
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18645,59,0.83 [0.49-1.42],0.5013844508726142
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18620,34,1.25 [0.68-2.28],0.4731381010848794
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19592,63,1.57 [1.06-2.31],0.0233734129403683
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19426,186,1.10 [0.83-1.46],0.5089438162269093
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2071,50,1.91 [1.34-2.74],0.0003866434036655
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2537,92,1.14 [0.78-1.67],0.4891398081147941
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19135,90,0.96 [0.63-1.45],0.8367734248140087
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19460,1200,1.05 [0.94-1.17],0.3826613302065449
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19338,752,1.03 [0.89-1.19],0.6816787080288822
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18839,253,1.10 [0.87-1.41],0.4196435218643211
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19637,784,1.07 [0.93-1.23],0.3463918996634466
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19689,67,1.48 [1.00-2.18],0.0517498817639813
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19585,732,1.07 [0.92-1.23],0.3812737165574751
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19660,420,1.03 [0.85-1.25],0.7652381300887662
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19590,195,1.04 [0.79-1.38],0.7769274836131003
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18675,89,1.27 [0.90-1.80],0.1744177897224527
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18676,90,0.87 [0.57-1.33],0.5283895872824065
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18651,65,1.26 [0.81-1.96],0.3095601421784733
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19578,853,1.00 [0.88-1.15],0.9794860357320148
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18958,233,0.75 [0.57-0.98],0.0362160416942697
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18911,58,0.95 [0.56-1.62],0.8538863979484418
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19350,110,0.87 [0.59-1.28],0.4919971906899861
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19562,322,1.11 [0.90-1.38],0.3281038013695466
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19037,184,1.16 [0.88-1.53],0.2938405098369836
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19515,120,0.92 [0.63-1.32],0.6404509601513914
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19279,554,1.07 [0.91-1.26],0.4045931161456955
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19180,135,1.07 [0.77-1.49],0.6881349664148065
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17635,2744,0.98 [0.91-1.06],0.5684414502484361
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19525,285,1.07 [0.85-1.35],0.5442822393175032
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19680,157,1.22 [0.92-1.63],0.1650130176175985
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19055,469,0.95 [0.79-1.14],0.5929689424548037
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19322,82,0.81 [0.52-1.27],0.3524420831832713
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19681,59,1.41 [0.91-2.19],0.1206752092779969
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18693,107,1.16 [0.81-1.67],0.4085323322401429
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18740,154,1.04 [0.76-1.42],0.8230952479227192
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18402,142,1.10 [0.80-1.51],0.5513171733866729
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18898,45,1.53 [0.98-2.40],0.0606595589142949
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18325,65,0.79 [0.48-1.31],0.3671867483192025
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18824,99,0.91 [0.60-1.37],0.6580718156327945
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18970,245,0.95 [0.74-1.23],0.7183007130695054
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18720,134,0.77 [0.54-1.10],0.150564706850494
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18341,81,0.95 [0.62-1.47],0.825788455034282
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18365,105,0.91 [0.62-1.33],0.6171530960912254
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17168,2277,1.02 [0.94-1.10],0.6974488822239131
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18667,81,1.03 [0.67-1.58],0.903739869991344
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19463,418,1.07 [0.88-1.29],0.511910318927946
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19113,68,1.03 [0.65-1.65],0.8930632711116141
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19202,157,1.00 [0.73-1.37],0.9874749256544236
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19498,96,1.11 [0.74-1.64],0.6205883569358488
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19657,118,1.15 [0.82-1.60],0.4148734111045584
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19582,95,1.15 [0.79-1.67],0.4635394959749883
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19460,58,1.16 [0.71-1.88],0.5566081795189823
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19459,57,1.36 [0.88-2.11],0.1672505766305094
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19600,1008,1.08 [0.95-1.21],0.234070372058486
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19359,767,1.06 [0.93-1.22],0.37892102938626
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18716,124,0.92 [0.64-1.32],0.6508934559438186
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18669,77,1.02 [0.66-1.58],0.9306864338144716
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19527,51,1.55 [1.06-2.28],0.0249860928462617
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19627,151,1.18 [0.88-1.59],0.2654683881767122
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19526,50,1.15 [0.69-1.92],0.5903637663179186
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza,17477,129,1.43 [1.08-1.90],0.0130931817770446
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17474,126,1.46 [1.10-1.93],0.0089166226019103
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12215,85,1.13 [0.75-1.72],0.5519679424221702
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19608,196,0.88 [0.66-1.17],0.3659375536477175
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13292,1480,1.11 [1.00-1.23],0.0406902479115296
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13592,1462,1.11 [1.00-1.22],0.0496350675005311
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19257,151,1.41 [1.09-1.84],0.009420995465851
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17434,86,1.50 [1.08-2.09],0.0159953564022704
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bronchiectasis,16492,436,1.22 [1.02-1.45],0.0280077591834047
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16118,62,1.80 [1.33-2.43],0.0001459158005525
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18739,2683,1.10 [1.02-1.18],0.0129356877865941
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18656,63,0.62 [0.37-1.04],0.0695223608145246
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18704,111,0.81 [0.55-1.19],0.2905291173713286
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19445,1361,1.05 [0.95-1.17],0.353289766569694
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18663,70,1.03 [0.65-1.62],0.9138820788306932
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17863,5125,1.11 [1.06-1.17],4.8760407151704645e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18887,294,1.12 [0.90-1.39],0.3150112486243474
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,18182,98,1.18 [0.81-1.73],0.3937493058899206
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Emphysema,16429,373,1.22 [1.01-1.48],0.0414831392939465
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18568,406,1.11 [0.92-1.33],0.2742898584430795
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19470,2122,1.21 [1.12-1.31],7.69315349659626e-07
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18603,441,1.17 [0.99-1.39],0.0691892807173029
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Later onset COPD,19235,1263,1.04 [0.94-1.16],0.4368306077681952
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19678,381,1.03 [0.85-1.25],0.7782230654670668
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,18679,86,1.16 [0.80-1.70],0.4397575888521988
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19450,1069,1.20 [1.07-1.34],0.0014021609260372
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19450,2248,1.28 [1.19-1.38],3.137779141369887e-11
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19229,636,0.96 [0.82-1.12],0.5651196404197866
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other pleural conditions,17255,53,1.26 [0.78-2.04],0.3378828995710569
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19578,515,1.19 [1.02-1.39],0.0303518156078683
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19584,1449,1.31 [1.20-1.44],2.3590017668381886e-09
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,18320,1118,1.31 [1.18-1.45],1.7894601601211305e-07
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural plaque,17417,215,1.04 [0.80-1.34],0.7871202459705952
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19229,1881,1.22 [1.13-1.33],1.1476040596326362e-06
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19582,285,1.13 [0.90-1.40],0.2885886983058152
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumothorax,17354,152,1.33 [1.01-1.76],0.0433527897164731
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pollen allergy,19685,164,0.87 [0.63-1.19],0.3748903237502817
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19136,73,1.26 [0.83-1.90],0.2825658173762159
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12191,61,1.50 [1.05-2.16],0.0276312395732558
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19435,1054,1.19 [1.07-1.33],0.0017348204544514
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18790,197,0.87 [0.65-1.16],0.3325722339773052
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Viral pneumonia,17591,243,1.24 [0.99-1.55],0.0578212715395464
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19268,194,1.21 [0.94-1.55],0.1422821669464437
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6357,101,1.54 [1.09-2.19],0.0155654472651392
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12606,52,1.56 [1.04-2.33],0.0301472908656569
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,19592,108,0.90 [0.61-1.31],0.5715149730998126
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute gastritis,13788,83,1.40 [1.00-1.98],0.050881341182774
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17994,166,1.34 [1.04-1.73],0.0227196065071121
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute peritonitis,19292,90,1.16 [0.80-1.69],0.4401782732520303
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18872,50,1.30 [0.81-2.08],0.2778958742309932
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Barrett oesophagus,14132,427,1.09 [0.91-1.31],0.3328372345248559
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17949,121,1.11 [0.79-1.54],0.5525508081482366
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19341,121,1.09 [0.78-1.52],0.6246955637224929
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,18011,183,1.25 [0.97-1.61],0.0847960887764142
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,18710,882,1.29 [1.15-1.45],1.0103490954343124e-05
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,13995,290,1.03 [0.82-1.30],0.7825292813442831
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17874,46,1.11 [0.65-1.90],0.709174933582405
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19579,110,1.37 [1.02-1.83],0.0378584875131771
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,18248,101,1.52 [1.13-2.05],0.0055172149105328
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Collagenous colitis,18205,86,1.38 [0.93-2.06],0.1106476718970059
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19596,140,1.13 [0.83-1.54],0.4451222732842392
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,19458,1735,1.01 [0.92-1.11],0.8808101868327736
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,18187,68,1.68 [1.21-2.32],0.0018274642571908
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19394,52,1.34 [0.85-2.12],0.2046861762486585
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18182,63,1.61 [1.13-2.30],0.0091505186353626
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,19168,154,1.12 [0.83-1.51],0.4498054910042166
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17055,2155,1.03 [0.95-1.12],0.516547396746778
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,19616,132,0.96 [0.69-1.35],0.8270553903607218
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,19592,770,1.14 [1.00-1.30],0.0460625462587007
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17553,3848,1.05 [0.98-1.11],0.1642498080639229
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19409,395,1.04 [0.86-1.26],0.6812998271744788
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19625,423,1.16 [0.97-1.39],0.094837531309767
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19089,75,0.87 [0.54-1.38],0.5473963482341867
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18987,47,1.38 [0.86-2.22],0.179518790959898
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19422,1275,1.21 [1.09-1.34],0.0002176944870252
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of tongue,18995,76,0.98 [0.63-1.53],0.9274035024763028
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19107,1279,1.23 [1.11-1.36],4.653286792086194e-05
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15739,3185,1.06 [0.99-1.14],0.0793560089560551
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13909,204,1.19 [0.93-1.53],0.1663268881759433
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19609,164,1.04 [0.78-1.40],0.7851412076701466
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19669,18,0.37 [0.14-0.98],0.0447124680333107
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18950,128,1.36 [1.04-1.79],0.0263005501251538
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12646,92,1.40 [1.00-1.96],0.0527798031951666
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14187,482,1.14 [0.96-1.35],0.1484233290938686
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,14053,348,1.20 [0.99-1.46],0.0576887668909024
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15935,2230,1.04 [0.96-1.13],0.3218652333762394
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14239,534,1.23 [1.06-1.43],0.0077919691588124
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14300,6952,1.02 [0.97-1.07],0.3781348647804896
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,19198,1051,1.19 [1.07-1.33],0.0019114607841353
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19057,43,0.77 [0.41-1.43],0.4040011125923421
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13386,994,1.06 [0.94-1.20],0.3673869814642403
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18880,58,1.16 [0.74-1.84],0.5158860971189837
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,17962,3062,1.03 [0.96-1.10],0.4723273810541103
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,19670,17,0.44 [0.16-1.18],0.1022736195154851
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impaction of intestines,12617,63,1.39 [0.89-2.15],0.1456204182995749
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,15825,925,0.98 [0.87-1.11],0.7957436507432829
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14998,98,0.88 [0.59-1.29],0.5039876091083013
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12649,95,1.17 [0.80-1.73],0.4220365893645449
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18267,120,1.39 [1.03-1.89],0.0327991577829783
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12982,428,1.26 [1.04-1.53],0.0157898623104139
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19670,275,1.22 [0.99-1.51],0.0567070961047882
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18782,663,1.32 [1.15-1.50],5.3721403293082993e-05
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19046,927,1.26 [1.12-1.41],0.0001179988586727
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13890,185,1.00 [0.75-1.33],0.9940425401261171
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,14301,596,1.01 [0.86-1.18],0.9506251412797548
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19645,112,1.20 [0.84-1.70],0.315805477846276
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14968,68,1.31 [0.86-1.99],0.2028007311598318
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13708,1154,1.08 [0.97-1.21],0.158654573873549
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18124,296,1.02 [0.81-1.28],0.8752953959608853
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17953,125,1.22 [0.88-1.68],0.2367726806809989
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14183,1629,1.07 [0.98-1.18],0.1407299965902544
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17735,5181,1.04 [0.99-1.10],0.1227542016894915
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18968,181,1.01 [0.76-1.36],0.9313593599543256
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,19456,634,1.16 [1.01-1.34],0.0422237594431202
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14363,658,1.07 [0.93-1.24],0.3476908269743792
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18002,174,1.05 [0.78-1.41],0.7447633441581913
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19561,359,1.17 [0.96-1.42],0.1155881440970486
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14625,920,1.16 [1.03-1.31],0.0141657790661672
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19210,1063,1.19 [1.06-1.33],0.0022709353760417
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19162,148,1.11 [0.82-1.51],0.4976682347408157
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14326,1772,1.03 [0.94-1.13],0.5301333786974135
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15531,1826,1.04 [0.95-1.13],0.4369648360980347
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18921,99,1.22 [0.86-1.73],0.2705659319981741
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18937,818,1.28 [1.14-1.45],6.865946241321118e-05
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12919,365,1.24 [1.03-1.50],0.0250920717954254
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19666,22,0.44 [0.18-1.06],0.0678291936137216
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13063,509,1.16 [0.98-1.37],0.0784857643094357
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18285,138,1.07 [0.78-1.48],0.6624104204697989
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19682,42,1.19 [0.67-2.11],0.5435851563488363
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19008,80,1.19 [0.78-1.80],0.4216570436684963
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Toxic colitis,18190,71,1.38 [0.91-2.08],0.1279693360505245
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14004,299,1.22 [1.00-1.50],0.0536391048540065
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18264,145,1.23 [0.91-1.66],0.177240473759126
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18236,117,1.32 [0.96-1.83],0.0866578869892823
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,15118,218,1.01 [0.78-1.30],0.9395992063183576
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12758,204,1.08 [0.82-1.42],0.5736018691955622
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,15130,230,1.25 [0.98-1.58],0.0672479876710621
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Volvulus,12629,75,1.19 [0.77-1.83],0.4291646077286121
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19606,352,1.14 [0.94-1.38],0.1935152484102377
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19388,60,0.71 [0.42-1.20],0.2019594444987927
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17581,142,1.07 [0.77-1.48],0.6949640975628684
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19163,696,1.23 [1.08-1.41],0.0019140790461672
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18588,121,1.13 [0.81-1.57],0.4702295424551626
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17928,489,1.32 [1.14-1.54],0.0002884905862657
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19403,262,1.07 [0.84-1.35],0.5883742849020024
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19600,459,1.01 [0.85-1.21],0.8851419235589082
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19185,44,1.28 [0.77-2.13],0.3368422900720231
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18339,3115,1.10 [1.03-1.18],0.0048434533057283
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19325,361,1.08 [0.89-1.32],0.4245213793637343
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19211,247,1.03 [0.81-1.32],0.7928455635788338
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19369,902,1.18 [1.05-1.33],0.0065980725216999
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19677,49,0.82 [0.45-1.49],0.5163341708059483
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17493,54,1.40 [0.86-2.28],0.1756086864991276
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19018,54,1.28 [0.80-2.04],0.3024863722330695
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19391,250,1.05 [0.83-1.34],0.6872806467998726
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17939,500,1.04 [0.88-1.24],0.6365329196454688
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17519,80,0.85 [0.54-1.33],0.4831308580901567
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19622,74,1.37 [0.94-2.00],0.1050558900858299
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18652,185,0.98 [0.74-1.30],0.8724878899697
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19524,196,1.07 [0.82-1.40],0.6218700019248391
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19216,75,1.01 [0.65-1.57],0.961814552545882
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17502,63,1.18 [0.75-1.85],0.4821217200369765
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19174,1735,1.12 [1.02-1.22],0.0175192575446428
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17976,537,1.06 [0.90-1.24],0.5202699759519984
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17522,83,0.78 [0.50-1.21],0.2647619138350855
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19618,290,0.98 [0.77-1.23],0.8329778181544715
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19204,63,0.86 [0.52-1.43],0.5605210327354258
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19568,240,1.02 [0.79-1.30],0.8976055094747677
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19635,381,1.15 [0.95-1.38],0.1564586382129105
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17544,105,0.97 [0.66-1.42],0.8595695074466974
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17721,282,0.95 [0.75-1.21],0.6807966009108962
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19623,369,1.13 [0.93-1.37],0.2253351654012459
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17709,270,1.24 [1.00-1.53],0.0548665163130252
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19671,123,1.29 [0.94-1.76],0.1169974619295587
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16446,68,1.23 [0.78-1.92],0.3697440904751078
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17380,5429,1.05 [1.00-1.11],0.0754696492824127
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16180,4229,1.04 [0.98-1.10],0.2100104359671236
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16422,44,0.60 [0.33-1.12],0.1085539777418285
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16415,117,0.99 [0.69-1.43],0.9749800813663037
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16455,157,1.46 [1.14-1.87],0.0024887956933907
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19479,52,0.97 [0.56-1.68],0.9115190669276556
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16421,123,0.63 [0.43-0.93],0.0181370698551706
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13207,1256,1.03 [0.92-1.15],0.5843451482588304
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19516,210,1.10 [0.84-1.43],0.4898268587177767
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16768,470,1.02 [0.85-1.23],0.8244469660930853
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15966,6783,1.08 [1.03-1.13],0.001377207041513
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17572,103,0.97 [0.65-1.44],0.8681935111035775
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16530,152,1.33 [1.01-1.76],0.0413485195581003
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16808,430,0.93 [0.76-1.13],0.446687476123763
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18900,2602,1.06 [0.98-1.14],0.123854970569512
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16645,267,1.05 [0.83-1.32],0.6853451089713014
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16500,122,1.19 [0.83-1.71],0.337352275841736
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16478,100,0.87 [0.57-1.30],0.4906681646412885
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19039,83,0.89 [0.57-1.40],0.6141679866946499
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13640,1689,1.04 [0.95-1.15],0.3583741342093035
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12595,644,1.20 [1.06-1.37],0.0041682162953704
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19609,639,1.23 [1.08-1.40],0.0019503450840814
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12013,62,0.64 [0.38-1.10],0.1055675232266476
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12214,263,1.13 [0.89-1.43],0.3287040091456734
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16599,221,0.86 [0.66-1.13],0.284755526148944
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12359,408,1.11 [0.93-1.33],0.2653894028548998
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16366,68,1.50 [1.02-2.21],0.0390246636701955
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16856,558,1.00 [0.85-1.18],0.9982036223820742
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16551,253,1.05 [0.82-1.34],0.6946959649295983
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12333,382,1.09 [0.90-1.31],0.3854388679465182
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16436,58,1.67 [1.13-2.45],0.0092092958215253
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16426,48,0.97 [0.55-1.72],0.9207401415089764
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17538,69,1.45 [1.01-2.09],0.0459229797589192
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19333,1864,1.02 [0.92-1.12],0.7388297095718562
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18780,1311,0.95 [0.84-1.06],0.3361978210503807
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19552,455,1.28 [1.08-1.51],0.0038832086471768
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14573,2622,1.05 [0.97-1.13],0.2363668586412743
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11988,37,1.31 [0.78-2.19],0.3050382204484495
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16463,85,0.75 [0.48-1.17],0.2012776108138965
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12013,62,0.84 [0.50-1.40],0.4921829616130689
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12063,112,0.68 [0.45-1.01],0.0564974284405853
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17673,204,1.26 [0.98-1.61],0.0687560744681759
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17878,409,1.05 [0.86-1.28],0.6457919765976476
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19679,91,1.04 [0.69-1.56],0.8546463281553773
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17933,1635,1.11 [1.02-1.22],0.0228269266985015
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16438,60,1.24 [0.77-1.99],0.3759166949203949
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12079,128,0.97 [0.68-1.40],0.8777573797341481
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16955,657,1.13 [0.97-1.30],0.1080142614819483
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13782,1831,1.07 [0.98-1.17],0.1383209588245205
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19061,105,0.90 [0.61-1.35],0.6178658056173425
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19687,57,0.63 [0.37-1.10],0.1026647709465026
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16446,68,1.14 [0.73-1.77],0.5768639674742577
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17501,1123,1.21 [1.08-1.36],0.0006860779745596
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16466,88,1.44 [1.02-2.03],0.0378897724223739
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13698,1747,1.01 [0.92-1.11],0.8734538086696157
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17571,102,1.40 [1.02-1.92],0.0374181263812445
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16406,28,1.54 [0.86-2.75],0.1436044177613252
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16463,165,1.09 [0.81-1.47],0.5781799013352822
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16946,568,1.19 [1.02-1.39],0.0318336252050285
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19372,416,1.19 [0.98-1.43],0.0719940721653327
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16838,540,1.11 [0.94-1.31],0.2152453056552421
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19563,450,1.30 [1.11-1.54],0.0016278901321173
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19673,54,1.56 [1.07-2.28],0.0209026316715242
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16515,137,0.79 [0.55-1.12],0.1885970974565924
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15353,721,1.03 [0.89-1.19],0.6945465205884234
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16911,533,1.19 [1.01-1.40],0.034486715598329
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16618,240,1.07 [0.84-1.35],0.5985068339499315
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12015,64,1.14 [0.71-1.84],0.575552210517883
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14579,2628,1.04 [0.97-1.12],0.2904436968377741
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12647,696,1.02 [0.88-1.19],0.7468122603832381
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19262,306,1.13 [0.91-1.41],0.2675170542485217
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19650,62,0.90 [0.54-1.52],0.7040795532815296
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17472,57,1.31 [0.85-2.01],0.2217998635627807
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12009,58,0.64 [0.37-1.11],0.1096286528580883
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16388,90,1.09 [0.73-1.63],0.6691830217807639
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12413,462,1.27 [1.09-1.49],0.0029221039640379
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16661,283,0.97 [0.77-1.23],0.8094251114840317
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16529,231,1.19 [0.94-1.51],0.1414663799973888
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16513,215,1.00 [0.76-1.32],0.9913844251495156
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13899,59,1.16 [0.72-1.89],0.536815586560127
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19678,59,1.53 [1.05-2.23],0.0252448018613475
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16843,465,1.01 [0.84-1.21],0.8965564686944223
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19046,90,1.31 [0.88-1.93],0.1794963667224808
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18588,2210,1.12 [1.03-1.21],0.0053367173487823
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16503,125,1.35 [1.00-1.83],0.0496592303617365
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16865,567,0.97 [0.83-1.15],0.7454605782674246
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18509,225,1.10 [0.85-1.41],0.4761775651631574
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16495,197,0.90 [0.67-1.20],0.4667308538929511
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17934,1636,0.99 [0.90-1.10],0.9159218042967276
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17371,1073,1.01 [0.90-1.14],0.8120214062578783
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16426,48,0.73 [0.40-1.33],0.305998914272625
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19062,106,1.35 [0.94-1.93],0.1021048537235007
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16520,142,0.97 [0.70-1.36],0.8726737674061862
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16458,80,1.41 [0.96-2.07],0.0787033220123559
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12014,63,1.04 [0.65-1.67],0.8680539133943228
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18569,1780,1.36 [1.26-1.47],2.0564248000885097e-15
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7959,22,0.86 [0.35-2.12],0.7443202735347461
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10088,28,1.16 [0.53-2.50],0.7141705801559709
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19421,260,1.18 [0.95-1.47],0.1338985320990539
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19250,89,1.33 [0.96-1.84],0.0871412796520014
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18506,1717,1.56 [1.45-1.67],2.1598784015938457e-35
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19516,85,2.01 [1.67-2.41],1.3390276771729398e-13
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19467,327,1.37 [1.15-1.64],0.0005438125871982
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,16547,256,0.98 [0.76-1.25],0.8605559322366223
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dialysis,16859,70,0.33 [0.20-0.53],7.308694801727997e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8625,1787,1.24 [1.15-1.35],5.266579944751152e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10168,108,1.41 [1.01-1.97],0.0449777945392742
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7971,34,1.06 [0.52-2.13],0.8786250357629668
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8419,482,1.04 [0.86-1.25],0.6877971623025384
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16277,5215,1.19 [1.14-1.25],4.508228968105258e-12
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19495,64,1.72 [1.27-2.33],0.0004685732933304
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6938,100,0.94 [0.64-1.37],0.7316348263741334
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16812,272,1.13 [0.90-1.41],0.2853040626763229
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8356,1518,1.27 [1.17-1.38],2.2194475291545692e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10223,137,0.99 [0.69-1.42],0.9726413817361672
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6939,101,1.60 [1.21-2.13],0.0010733431062477
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16358,67,1.07 [0.67-1.72],0.7685053260296786
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8806,869,1.01 [0.88-1.16],0.8802270918836974
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6891,53,1.59 [1.05-2.40],0.0268810530079253
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7971,34,1.38 [0.77-2.49],0.2835698198797656
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19688,74,1.06 [0.68-1.65],0.8034979674461049
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19681,73,0.88 [0.55-1.41],0.5925339813300262
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18680,2389,1.13 [1.05-1.22],0.0013097985356051
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17086,795,1.07 [0.94-1.22],0.3271192318469965
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10104,44,1.48 [0.93-2.36],0.1001040917175174
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19632,492,1.41 [1.22-1.62],2.618763171242043e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6959,121,1.30 [0.96-1.76],0.0947667974996001
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6970,132,0.88 [0.63-1.23],0.4582202071507184
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6964,126,1.30 [0.97-1.76],0.0822208021033947
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19663,67,1.34 [0.89-2.02],0.165409006257917
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18152,1861,1.17 [1.07-1.27],0.0004149045319591
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10158,72,1.13 [0.70-1.84],0.6060950224959283
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8000,63,0.77 [0.45-1.32],0.3478073565802739
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8067,130,0.96 [0.66-1.38],0.8055096382367586
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7986,49,0.94 [0.52-1.73],0.8529675243197024
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8024,87,0.74 [0.47-1.17],0.1934061033994024
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16862,322,1.13 [0.92-1.38],0.2419898457650723
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19300,160,1.32 [1.01-1.72],0.0457333491661177
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8038,101,0.98 [0.64-1.48],0.9067703690343952
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7959,22,0.67 [0.27-1.64],0.3797243649875712
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8116,179,1.06 [0.78-1.43],0.71498244941564
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8017,80,1.19 [0.79-1.81],0.4004418776690002
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8118,181,0.82 [0.60-1.13],0.2232632965867561
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19476,45,1.39 [0.88-2.22],0.1609849756212745
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6964,126,1.33 [0.99-1.77],0.0551097615367908
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19483,2943,1.35 [1.27-1.43],7.105778592887305e-22
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16615,75,1.52 [1.09-2.13],0.0136959130581904
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16929,140,1.78 [1.45-2.17],1.9618750192244025e-08
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19193,32,0.67 [0.33-1.38],0.2773064975740547
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16515,224,1.10 [0.86-1.41],0.4522342759725233
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19497,336,1.19 [0.98-1.43],0.0807910012975915
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7970,33,0.98 [0.48-1.99],0.954824592496715
